Skip to content

Observation of the therapeutic effect of emergency intravitreal injection of triamcinolone acetonide and vancomycin in open ocular trauma - a multicenter randomized controlled clinical study

Observation of the therapeutic effect of intravitreal injection of triamcinolone acetonide and vancomycin in open ocular trauma - a multicenter randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104732
Enrollment
Unknown
Registered
2025-06-23
Start date
2025-06-24
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

open ocular trauma

Interventions

Control group::Intravitreal injection of vancomycin
Test group:intravitreal injection of vancomycin combined with TA

Sponsors

Tianjin Medical University General Hospital, Tianjin, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 and above; 2. Open ocular trauma, involving Zone III, with a high possibility of vitrectomy; 3. The first emergency surgery will be completed within 24 hours; 4. The patient voluntarily underwent a vitreoretinal surgery.

Exclusion criteria

Exclusion criteria: 1. Previous history of ocular trauma; 2. Previous history of ocular diseases such as glaucoma, uveitis, and vitreoretinal diseases; 3. Previous history of undergoing intraocular surgeries other than phacoemulsification for cataracts; 4. Patients who have previously or currently used high-dose corticosteroids; 5. Those who have adverse reactions to vancomycin and triamcinolone acetonide; 6. Patients with combined or highly suspected traumatic intraocular inflammation, intraocular foreign bodies, or optic canal fractures; 7. Patients who are pregnant or breastfeeding, have a history of mental illness, have a scarred constitution, and have severe systemic diseases; 8. For those who cannot undergo vitreoretinal surgery due to other reasons; 9. Those who cannot follow up regularly.

Design outcomes

Primary

MeasureTime frame
TPVR incidence and severity;Incidence of infectious endophthalmitis;

Countries

China

Contacts

Public ContactHua Yan

Tianjin Medical University General Hospital, Tianjin, China

zyyyanhua@tmu.edu.cn+86 135 1201 9587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026